MHRA’s Final Call to Comply with Windsor Framework Arrangements for Medicines from January 2025 MHRA is reminding MAHs to ensure they are prepared for the new Windsor Framework packaging and labelling measures for medicines from January 2025. MHRA will be responsible for licensing all medicines on the market in Northern Ireland under a UK-wide licence, and all medicines for the UK market must carry a ‘UK Only’ label or sticker. MHRA’s Final Call to Comply with Windsor Framework Arrangements for Medicines from January 2025
MHRA Marketing Authorisations Granted 1 to 14 November MHRA granted 1 OTC licence during 1 - 14 November 2024. MHRA Marketing Authorisations Granted 1 to 14 November
CMDh Report from October 2024 Meeting The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published the report from the CMDh meeting held on 15-16 October 2024. CMDh Report from October 2024 Meeting
MHRA Performance on Medicines Licence Applications The MHRA has released an update on the performance of medicines licence applications. MHRA Performance on Medicines Licence Applications
HERA Launched Stakeholders Hub HERA launches the Stakeholders Hub to strengthen collaboration for a resilient pharmaceutical supply chain in the EU. HERA Launched Stakeholders Hub
Webinar: An update on Extended Producer Responsibility (EPR) Scheme from OPRL PAGB members are invited to the final webinar with OPRL, covering OPRL’s work, consumer labelling benefits, and updates on the EPR Scheme. Webinar: An update on Extended Producer Responsibility (EPR) Scheme from OPRL
MHRA Windsor Framework Industry Webinar Recordings The MHRA has released the 2024 Windsor Framework Webinar Recordings . MHRA Windsor Framework Industry Webinar Recordings
New MHRA Chair: Anthony Harnden Appointed MHRA has elected a new chair. New MHRA Chair: Anthony Harnden Appointed
NHS England’s Sustainable Supplier Initiative NHS England's Sustainable Supplier Accelerator supports suppliers in meeting and surpassing the net zero and sustainability goals outlined in the NHS Net Zero Supplier Roadmap. NHS England’s Sustainable Supplier Initiative
MHRA Performance Data for Assessment of New Marketing Authorisations, Variations and Clinical Trial Authorisation The MHRA performance metrics for new marketing authorisation applications, variations, and clinical trial authorisation assessment have been updated. MHRA Performance Data for Assessment of New Marketing Authorisations, Variations and Clinical Trial Authorisation
MHRA Future Medical Device Regulations Consultation MHRA has launched a public consultation to seek views on proposals to update four areas of the future regulatory framework for medical devices and in vitro diagnostic (IVD) devices. MHRA Future Medical Device Regulations Consultation
New webinar: A new era for patient access to self-care: Healthcare Reinvention at Boots UK This webinar is aimed at those who are interested in new innovations in consumer healthcare and those interested to see how healthcare innovation has thrived in our highly regulated environment. New webinar: A new era for patient access to self-care: Healthcare Reinvention at Boots UK
